Skip to content

MDMA: all studies

Page 318 of 345: studies 3,171 to 3,180 of 3,446, newest first. Back to the MDMA overview

Research

The new psychoactive substances 5-(2-aminopropyl)indole (5-IT) and 6-(2-aminopropyl)indole (6-IT) interact with monoamine transporters in brain tissue.

Neuropharmacology February 2016 Julie A. Marusich, Kateland R Antonazzo, Bruce E. Blough et al.

In recent years, use of psychoactive synthetic stimulants has grown rapidly. 5-(2-Aminopropyl)indole (5-IT) is a synthetic drug associated with a number of fatalities, that appears to be one of the newest 3,4-methylenedioxymethamphetamine (MDMA) replacements. Here, the monoamine-releasing properties of 5-IT, its structural isomer 6-(2-aminopropyl)indole (6-IT), and MDMA were compared using in...

DOI: 10.1016/j.neuropharm.2015.09.004 (opens in new tab) Full text (opens in new tab) 3,4-Methylenedioxymethamphetamine MDMA 5-2-aminopropylindole 5-it 6-2-aminopropylindole 6-it Locomotor activity +2

Novel psychoactive benzofurans strongly increase extracellular serotonin level in mouse corpus striatum.

The Journal of Toxicological Sciences 2016 Tatsu Fuwa, Jin Suzuki, Toyohito Tanaka et al.

We examined the effects of three benzofurans [1-(Benzofuran-5-yl)-N-methylpropan-2-amine (5-MAPB), 1-(Benzofuran-2-yl)-N-methylpropan-2-amine (2-MAPB), and 1-(Benzofuran-5-yl)-N-ethylpropan-2-amine (5-EAPB)] on the extracellular monoamine level in mouse corpus striatum by the microdialysis method and compared them with the effects of psychoactive 3,4-Methylenedioxymethamphetamine (MDMA). The...

Dissociazione creativa: il “trip” dell’artista

AMS Acta 2016 Giuseppe Galetta

Un’allucinazione vissuta consensualmente abbandonandosi all’oblio della coscienza: un “viaggio” allucinante nelle profondità dell’inconscio, intrapreso dall’artista nel rischioso tentativo di raggiungere senza certezza uno stato di “superiore” ispirazionee di mistica illuminazione, lasciando affiorare le proprie visioni ed i propri fantasmi interiori dalle nebbie lisergiche dell’estasi chimica...

Pharmacokinetics, pharmacodynamics and toxicology of new psychoactive substances (NPS): 2C-B, 4-fluoroamphetamine and benzofurans.

Drug and Alcohol Dependence December 1, 2015 Johanna J Nugteren-Van Lonkhuyzen, Antoinette J H P van Riel, Tibor M Brunt et al. 48 citations

Recently, the number of new psychoactive substances (NPS) appearing on the illicit drug market has shown a marked increase. Although many users perceive the risk of using NPS as medium or low, these substances can pose a serious health risk and several NPS have been implicated in drug-related deaths. In Europe, frequently detected NPS are 4-bromo-2,5-dimethoxyphenethylamine (2C-B),...

DOI: 10.1016/j.drugalcdep.2015.10.011 (opens in new tab) Full text (opens in new tab) Designer drugs Legal highs Research chemicals New psychoactive substances +15

Recreational phenethylamine poisonings reported to a French poison control center.

Drug and Alcohol Dependence September 1, 2015 Gaël Le Roux, Chloé Bruneau, Benedicte Lelievre et al.

Over the last decade, use of phenethylamines has become increasingly prevalent. This study aimed to describe typical aspects of phenethylamine poisoning in order to better inform patient care. Phenethylamine poisoning cases reported to the Poison Control Center of Angers, France, from January, 2007 to December, 2013 were examined. Clinical findings were examined in 105 patients, including...

DOI: 10.1016/j.drugalcdep.2015.05.048 (opens in new tab) Full text (opens in new tab) Amphetamines Designer drugs Phenethylamines Poison control center +1

Toxicology Rounds

Emergency Medicine News September 1, 2015 Leon Gussow

Figure: Phenethylamine, top left; 2C-I, top right; and 25I-NBOMe, below.FigureAt least 19 young people died between March 2012 and November 2013 from the so-called N-BOMB drugs, synthetic hallucinogens that can be deadlier than LSD, according to the U.S. Drug Enforcement Administration. Chemist Alexander Shulgin developed a series of hallucinogenic 2C drugs in the early 1970s by adding...

Hallucinogens and Dissociatives

ASAM Handbook of Addiction Medicine August 1, 2015 D. Rastegar, Michael I. Fingerhood

Hallucinogens, also referred to as psychedelics, are a broad range of agents that alter perception in different ways. An estimated 1.3 million Americans are current (past month) users of hallucinogens. Hallucinogen use is highest among young adults; 3,4-methylenedioxymethamphetamine (MDMA) is the most commonly used agent, followed by lysergic acid diethylamide (LSD) and phencyclidine (PCP)....

Drogas pesadas em discussão no Primeiro Seminário sobre Psicodélicos do Rio de Janeiro

Argumentum June 29, 2015 Sandro Rodrigues, Fernando Rocha Beserra

The article examines the harms caused by the way how the prohibitionism has been approaching the human relationship with psychedelic substances, which has led to the necessity of promoting a clinical and political debate, carried out through the First Seminar about Psychedelic Drugs in Rio de Janeiro. Based on such debate, the text introduces a terminology about psychedelia and presents some...

Therapeutic potential of psychedelic agents

The British Journal of Psychiatry May 1, 2015 Matthew M. Nour, Jacob Krzanowski 2 citations

Therapeutic potential of psychedelic agentsAmphetamine, methylphenidate, morphine, heroin and ketamine are all drugs that can potentially be used clinically but, whenever we hear the word MDMA, the first thoughts that come to mind are of ecstasy, rave parties and people behaving in an odd manner and experiencing hallucinations, paranoia and disinhibition.Recently, there has been a lot of...

Endogenous serotonin facilitates hippocampal long-term potentiation at CA3/CA1 synapses.

Journal of Neural Transmission February 2015 Boris Mlinar, Gabriella Stocca, Renato Corradetti

Encoding of episodic memory requires long-term potentiation (LTP) of neurotransmission at excitatory synapses of the hippocampal circuitry. Previous data obtained with the application of exogenous 5-hydroxytryptamine (5-HT) in hippocampal slices indicate that 5-HT blocks LTP, which contrasts with the facilitatory effect of selective serotonin reuptake inhibitors (SSRIs) on learning and memory...